Cargando…
Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collec...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464784/ https://www.ncbi.nlm.nih.gov/pubmed/28620649 http://dx.doi.org/10.1097/TXD.0000000000000685 |
_version_ | 1783242831771467776 |
---|---|
author | Caicedo, Luis A. Sabogal, Angie Serrano, Oscar Villegas, Jorge I. Botero, Verónica Agudelo, María T. Lotero, Viviana Dávalos, Diana Manzi, Eliana Aristizabal, Ana M. Gomez, Catalina Echeverri, Gabriel J. |
author_facet | Caicedo, Luis A. Sabogal, Angie Serrano, Oscar Villegas, Jorge I. Botero, Verónica Agudelo, María T. Lotero, Viviana Dávalos, Diana Manzi, Eliana Aristizabal, Ana M. Gomez, Catalina Echeverri, Gabriel J. |
author_sort | Caicedo, Luis A. |
collection | PubMed |
description | BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collection of data was performed from pediatric patients with diagnosis of hepatoblastoma. Variables included demographic, diagnostic tools and histological classification; chemotherapy and surgical treatment; and outcomes and patient survival. The PRETEXT classification was applied, which included the risk evaluation, and according to the medical criterion in an individualized way, underwent resection or transplant. The morbidity of patients was evaluated by the Clavien-Dindo classification. Statistical analysis was performed according to the distribution of data and the survival analysis was carried out using the Kaplan-Meier method. RESULTS: The patients (n = 16) were divided in a resection group (n = 8) and a transplant group (n = 8). The median age at the time of diagnosis was 13.5 months. The motive for the initial consultation was the discovery of a mass; all patients had high levels of α-fetoprotein and an imaging study. Ten of 16 patients required chemotherapy before the surgical procedure. In the resection group, 5 of 8 patients were classified as Clavien I and 4 of 8 patients of the transplant group were classified as Clavien II. Patient survival at 30 months was 100% in the resection group and 65% in the liver transplantation group. CONCLUSIONS: To our knowledge, this is the first case report of pediatric patients with hepatoblastoma and liver resection or transplant in Colombia and Latin America. Our results are comparable with the series worldwide, showing that resection and transplant increase the survival of the pediatric patients with hepatoblastoma. It is important to advocate for an increase of reporting in the scientific literature in Latin America. |
format | Online Article Text |
id | pubmed-5464784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-54647842017-06-15 Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center Caicedo, Luis A. Sabogal, Angie Serrano, Oscar Villegas, Jorge I. Botero, Verónica Agudelo, María T. Lotero, Viviana Dávalos, Diana Manzi, Eliana Aristizabal, Ana M. Gomez, Catalina Echeverri, Gabriel J. Transplant Direct Liver Transplantation BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collection of data was performed from pediatric patients with diagnosis of hepatoblastoma. Variables included demographic, diagnostic tools and histological classification; chemotherapy and surgical treatment; and outcomes and patient survival. The PRETEXT classification was applied, which included the risk evaluation, and according to the medical criterion in an individualized way, underwent resection or transplant. The morbidity of patients was evaluated by the Clavien-Dindo classification. Statistical analysis was performed according to the distribution of data and the survival analysis was carried out using the Kaplan-Meier method. RESULTS: The patients (n = 16) were divided in a resection group (n = 8) and a transplant group (n = 8). The median age at the time of diagnosis was 13.5 months. The motive for the initial consultation was the discovery of a mass; all patients had high levels of α-fetoprotein and an imaging study. Ten of 16 patients required chemotherapy before the surgical procedure. In the resection group, 5 of 8 patients were classified as Clavien I and 4 of 8 patients of the transplant group were classified as Clavien II. Patient survival at 30 months was 100% in the resection group and 65% in the liver transplantation group. CONCLUSIONS: To our knowledge, this is the first case report of pediatric patients with hepatoblastoma and liver resection or transplant in Colombia and Latin America. Our results are comparable with the series worldwide, showing that resection and transplant increase the survival of the pediatric patients with hepatoblastoma. It is important to advocate for an increase of reporting in the scientific literature in Latin America. Lippincott Williams & Wilkins 2017-05-25 /pmc/articles/PMC5464784/ /pubmed/28620649 http://dx.doi.org/10.1097/TXD.0000000000000685 Text en Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Liver Transplantation Caicedo, Luis A. Sabogal, Angie Serrano, Oscar Villegas, Jorge I. Botero, Verónica Agudelo, María T. Lotero, Viviana Dávalos, Diana Manzi, Eliana Aristizabal, Ana M. Gomez, Catalina Echeverri, Gabriel J. Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title | Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title_full | Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title_fullStr | Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title_full_unstemmed | Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title_short | Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center |
title_sort | hepatoblastoma: transplant versus resection experience in a latin american transplant center |
topic | Liver Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464784/ https://www.ncbi.nlm.nih.gov/pubmed/28620649 http://dx.doi.org/10.1097/TXD.0000000000000685 |
work_keys_str_mv | AT caicedoluisa hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT sabogalangie hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT serranooscar hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT villegasjorgei hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT boteroveronica hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT agudelomariat hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT loteroviviana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT davalosdiana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT manzieliana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT aristizabalanam hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT gomezcatalina hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter AT echeverrigabrielj hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter |